August 6, 2026

TRT in Bloomington: A Physician’s Guide to Starting, Monitoring, and Adjusting Therapy

By Kyle Kingsley, MD
Medical Director, Lite Medical PLLC

Estimated Reading Time: 14 minutes

Starting testosterone replacement therapy is a decision that deserves more than a quick prescription. For men in Bloomington who have finally had their labs run, confirmed low testosterone, and are ready to move forward, the real complexity begins at the start button — not before it.

What delivery method suits your lifestyle? How quickly should you expect to feel different? When do labs get rechecked, and what do those numbers actually mean? What happens when results plateau or side effects emerge?

These are the questions that determine whether TRT works for you — or whether it becomes another treatment you tried and gave up on.

At Lite Medical PLLC, physician-led testosterone replacement is built around a structured, evidence-based protocol that doesn’t end at the prescription pad. It continues through every monitoring visit, every lab draw, and every adjustment decision. This guide walks you through that entire process: what starting therapy looks like, how we monitor it over time, and what meaningful adjustment actually involves.

Key Takeaways

TRT requires a clinical plan — not just a diagnosis and a prescription
Delivery method, starting dose, and injection frequency all influence how therapy feels and performs
Endocrine Society and AUA guidelines both emphasize baseline labs and structured monitoring
Testosterone levels alone don’t tell the full story — SHBG, estradiol, hematocrit, and PSA all matter
Most men don’t feel the full effect of TRT until 8–16 weeks in; early impatience often leads to unnecessary dose escalation
Monitoring is not optional — it’s the mechanism by which therapy actually gets optimized
Lite Medical’s physician-led approach means adjustments are clinically reasoned, not driven by how you feel on any given day

What Is TRT and Why Does Starting Therapy Require a Plan?
The Biology Behind Testosterone Decline
Who Should Consider TRT in Bloomington?
How Lite Medical Evaluates Candidates Before Starting TRT
Starting TRT: Protocols, Delivery Methods, and What to Expect
Monitoring TRT: Labs, Timelines, and Adjustments
Myths vs. Facts About TRT
Lite Medical’s Clinical Approach
TRT in Bloomington: What We See at Lite Medical
Frequently Asked Questions
Related Lite Medical Services
Related Articles
References
Medical Disclaimer
Medication & Regulatory Disclosure

What Is TRT and Why Does Starting Therapy Require a Plan?

Testosterone replacement therapy is the clinical restoration of testosterone to physiologically adequate levels in men whose production has declined beyond a threshold that produces measurable symptoms. The condition it treats — hypogonadism — is defined not by a single lab number but by the combination of low serum testosterone and symptoms attributable to that deficiency.

That distinction matters. Because TRT isn’t a supplement you adjust based on how you feel week to week. It’s a hormonal intervention with downstream effects on red blood cell production, estradiol levels, cardiovascular parameters, fertility, and prostate tissue. Starting it without a structured plan is how patients end up on doses that don’t fit them, monitoring schedules that miss problems, and protocols they eventually abandon.

A well-designed TRT plan establishes three things before the first injection: the clinical rationale (confirmed low testosterone with symptomatic correlation), the delivery method suited to the patient’s life and physiology, and the monitoring schedule that will catch problems and guide adjustments over time.

Without all three, you’re not really starting TRT. You’re just starting testosterone. The difference, in clinical outcomes, is significant.

The Biology Behind Testosterone Decline

Testosterone production follows a predictable arc across a man’s life. Peak levels typically occur in the late teens and early twenties. From roughly age 30 forward, production declines at an average rate of 1–2% per year — a gradual process that rarely announces itself until the cumulative deficit becomes symptomatic.

The hypothalamic-pituitary-gonadal (HPG) axis governs this system. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which signals the pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH drives the Leydig cells in the testes to produce testosterone. As testosterone rises, it feeds back to suppress GnRH and LH — a negative feedback loop that keeps levels in range.

When the testes can no longer respond adequately to LH signaling — a condition called primary hypogonadism — testosterone falls while LH rises. When the problem is upstream, in the pituitary or hypothalamus (secondary hypogonadism), both testosterone and LH are low. The distinction guides treatment decisions.

Meanwhile, sex hormone-binding globulin (SHBG) — a protein that binds testosterone and renders it biologically inactive — tends to rise with age. This means total testosterone can appear adequate on paper while free testosterone (the active fraction) is meaningfully reduced. Men with elevated SHBG often feel low-T symptoms at total testosterone levels that wouldn’t raise a flag on a standard lab report.

Who Should Consider TRT in Bloomington?

Men With Confirmed Biochemical Hypogonadism

Clinical candidacy for TRT requires documented low testosterone on at least two morning samples, combined with symptoms consistent with androgen deficiency. The Endocrine Society defines this as total testosterone below 300 ng/dL, though the symptom threshold is more nuanced than any single cutoff suggests. Men with low-normal total T but elevated SHBG may also benefit from evaluation of free testosterone.

Men Experiencing Persistent Fatigue and Cognitive Slowness

Fatigue attributed to lifestyle — poor sleep, stress, overwork — is often accurate. But in men with confirmed low testosterone, fatigue has a hormonal component that no amount of sleep hygiene will address. The same applies to the cognitive dullness some patients describe as brain fog: difficulty concentrating, slow recall, reduced motivation. These symptoms don’t always respond to lifestyle alone.

Men With Reduced Libido and Sexual Function

Testosterone drives libido in men. When it drops significantly, sexual interest often follows — and this is one of the most consistent symptoms reported by men with hypogonadism. Some patients also report erectile dysfunction, though ED has multiple contributing factors and testosterone is not always the primary one. A thorough evaluation helps separate the treatable hormonal component from other causes.

Men With Body Composition Changes Resistant to Effort

Muscle loss and fat accumulation — particularly central adiposity — are classic features of androgen deficiency. Men who are training consistently and eating well but losing muscle or gaining abdominal fat despite those efforts may have a hormonal explanation worth investigating.

How Lite Medical Evaluates Candidates Before Starting TRT

Before any prescription is written, a thorough baseline evaluation establishes both candidacy and a starting point for monitoring. At Lite Medical, this includes a structured symptom review alongside a comprehensive lab panel.

Baseline labs typically include total testosterone (ideally drawn before 10 AM, when levels peak), free testosterone, SHBG, LH, FSH, estradiol, complete blood count with hematocrit, PSA, comprehensive metabolic panel, and thyroid function. LH and FSH help distinguish primary from secondary hypogonadism — a distinction that matters both clinically and for men who want to preserve fertility options.

Physical examination and medical history review screen for contraindications: polycythemia, untreated sleep apnea, active prostate cancer, and severe uncontrolled heart failure are among the conditions that require additional evaluation before initiation.

This pre-treatment picture doesn’t just confirm candidacy. It establishes the baseline against which all future lab values will be compared. Without it, monitoring loses much of its clinical utility.

Starting TRT: Protocols, Delivery Methods, and What to Expect

The Endocrine Society and AUA both provide clinical guidance on initiating testosterone replacement, and while both endorse injectable testosterone as effective and well-tolerated, neither mandates a single approach. Delivery method selection depends on patient preference, tolerance, and lifestyle factors.

Injectable testosterone (testosterone cypionate or enanthate) remains the most commonly used formulation at Lite Medical. Subcutaneous injections, typically administered once or twice weekly, provide steady serum levels and are straightforward for self-administration after initial training. Weekly or twice-weekly subcutaneous dosing is generally preferred over larger infrequent intramuscular doses because it reduces the peaks and troughs that can cause energy fluctuations and mood variability.

Topical gels and creams provide daily dosing and avoid injections, which some patients prefer. The primary limitation is transfer risk to partners and children. Absorption also varies between individuals, making dose calibration less predictable than with injectables.

Nasal testosterone gel (Natesto) is an option for men who want to preserve fertility during therapy, as its short daily absorption profile has less suppressive effect on LH and FSH than other formulations.

Starting doses are intentionally conservative. The goal at initiation is not to maximize testosterone — it’s to establish a controlled baseline that can be titrated upward with monitoring data. Most men don’t feel the full effect of TRT in the first few weeks. Meaningful response in energy, libido, body composition, and mood typically requires 8–16 weeks of stable levels.

Monitoring TRT: Labs, Timelines, and Adjustments

This is where TRT either works or doesn’t. Therapy without monitoring is guesswork. Monitoring without adjustment is bureaucracy. Effective TRT requires both — and the discipline to let lab data, not day-to-day subjective experience, guide dosing decisions.

The standard monitoring schedule at Lite Medical follows Endocrine Society and AUA guidance:

Weeks 6–8: First follow-up labs. Total and free testosterone, hematocrit, and estradiol. Timing of the draw relative to injection matters — mid-cycle draws (3–4 days after a weekly injection) give the most representative trough-to-peak average.
Months 3–6: Second monitoring visit. PSA added if not previously flagged. Full CBC to assess hematocrit trend. Symptom reassessment.
Annually thereafter: Full panel including testosterone, hematocrit, PSA, metabolic markers, and lipids.

Hematocrit deserves particular attention. Testosterone stimulates erythropoiesis — red blood cell production. In some patients, hematocrit rises to levels that increase blood viscosity and cardiovascular risk. The AUA recommends holding or reducing dose if hematocrit exceeds 54%. This is not a theoretical concern; it’s a real monitoring target that requires consistent lab draws.

Estradiol rises on TRT because testosterone aromatizes to estrogen. Some aromatization is normal and beneficial — estrogen supports bone density, cardiovascular health, and libido. But excessive conversion can cause fluid retention, mood changes, and nipple sensitivity. When estradiol rises significantly, the response may involve dose reduction, injection frequency adjustment, or in some cases, an aromatase inhibitor — a decision made clinically, not reflexively.

Dose adjustments are based on the combination of lab values and symptoms, not either alone. A patient with testosterone in the mid-normal range who remains symptomatic warrants a closer look at free testosterone and SHBG before increasing dose. A patient with high-normal testosterone who feels well doesn’t need escalation simply because a higher number is theoretically possible.

Myths vs. Facts About TRT

Myth: TRT causes prostate cancer.
Fact: Decades of research have not established a causal link between testosterone therapy and prostate cancer development. Current evidence, including large observational studies reviewed by the AUA, does not support withholding TRT from otherwise eligible men due to prostate cancer fear. Men with active untreated prostate cancer are not candidates, but TRT does not appear to initiate malignancy in healthy prostate tissue.

Myth: Once you start TRT, you can never stop.
Fact: TRT can be discontinued. Natural testosterone production — which is suppressed during therapy — does typically recover after stopping, though recovery time varies based on duration of therapy and individual factors. Men who wish to preserve fertility or may want to discontinue therapy should discuss this before starting.

Myth: TRT is only for older men.
Fact: Hypogonadism occurs across the age spectrum. Secondary hypogonadism — driven by pituitary or hypothalamic dysfunction — is increasingly identified in men under 40. Clinical candidacy is based on labs and symptoms, not age.

Myth: Higher testosterone is always better.
Fact: The goal of TRT is restoration to physiologically adequate levels — not supraphysiologic maximization. Chasing the highest possible number increases the risk of side effects including polycythemia, estradiol elevation, and suppression of endogenous production, without proportional clinical benefit.

Myth: TRT is the same as anabolic steroid use.
Fact: Therapeutic TRT doses are designed to restore normal physiologic levels. Anabolic steroid use involves supraphysiologic doses with fundamentally different risk profiles. The two are not clinically comparable.

Myth: Side effects on TRT mean the therapy isn’t working.
Fact: Side effects often indicate a need for protocol adjustment — not discontinuation. Elevated hematocrit, excessive estradiol conversion, or injection site irritation are typically addressable through dose modification, frequency adjustment, or formulation change.

Lite Medical’s Clinical Approach

Lite Medical PLLC is a physician-led, cash-pay clinic focused on hormone optimization, metabolic health, and longevity medicine. Our testosterone replacement program is built around physician oversight at every stage — not delegated to a coordinator and only reviewed if something goes wrong.

Every patient who starts TRT at Lite Medical receives:

A comprehensive pre-treatment evaluation with full baseline labs
A protocol designed for their specific physiology, preferences, and health history
Structured monitoring at evidence-based intervals
Physician-reviewed adjustments based on lab data and symptom response
Direct access to clinical guidance between visits

We’re cash-pay because we believe the physician-patient relationship works better without insurance intermediaries driving clinical decisions. Our patients in Bloomington and across the Twin Cities come to us because they want their hormones managed with the same rigor their cardiovascular or metabolic health would receive from a specialist.

If you’re considering TRT and haven’t started yet, a free consultation is the right first step. We’ll review what you’ve had tested, what symptoms you’re experiencing, and whether our program fits your clinical picture.

TRT in Bloomington: What We See at Lite Medical

Bloomington sits at the heart of the Twin Cities working professional corridor, a few minutes from Mall of America along Nicollet Avenue. The men who find us at our 6414 Nicollet Ave clinic tend to arrive later than they probably should have — having spent months, sometimes years, attributing symptoms to stress or aging before seeking a clinical answer. That skepticism, once addressed with real data and a clear explanation, often turns into some of our most engaged patients. The education-first approach resonates here. Men don’t just want a prescription — they want to understand the reasoning behind it.

Frequently Asked Questions

How long does it take to feel the effects of TRT?

Most patients begin noticing some changes within 3–6 weeks — often improved sleep and mood first, followed by energy and libido over the following weeks. Body composition changes, including muscle gain and fat reduction, typically require 3–6 months of stable therapy to become noticeable. The Endocrine Society guidelines note that full response to TRT may take up to 12 months. Patience during the early phase is clinically important; premature dose escalation based on incomplete response is a common error.

How often do I need to inject testosterone?

At Lite Medical, most patients use testosterone cypionate via subcutaneous injection once or twice per week. Twice-weekly dosing generally produces more stable serum levels than weekly, reducing the energy and mood variability that can occur with larger, less frequent doses. Injection schedule is determined during your initial evaluation and may be adjusted based on monitoring data and your preference.

Will TRT affect my fertility?

Exogenous testosterone suppresses the HPG axis, reducing LH and FSH signaling to the testes and decreasing — sometimes eliminating — sperm production during therapy. This effect is typically reversible after discontinuation, but recovery is not guaranteed and takes time. Men who may want children in the future should discuss this before starting TRT. HCG co-administration is one strategy used to maintain testicular function during therapy.

What labs do you monitor on TRT?

We monitor total and free testosterone, hematocrit, estradiol, PSA, and a basic metabolic panel on a schedule that follows Endocrine Society and AUA guidance: typically at 6–8 weeks post-initiation, then at 3–6 months, and annually thereafter once stable. Additional markers may be monitored depending on individual health history. Lab timing relative to injection is standardized to ensure comparable data across visits.

Can testosterone levels get too high on TRT?

Yes. Supraphysiologic testosterone levels are not the goal of therapeutic TRT and carry real risks, including excessive aromatization to estradiol, polycythemia (elevated hematocrit), and suppression of endogenous production. If labs show testosterone above the upper physiologic range, dose reduction is the appropriate clinical response — not continuation at the same level.

What happens if my hematocrit gets too high?

Elevated hematocrit — above approximately 54% by AUA guidance — increases blood viscosity and raises the theoretical risk of thrombotic events. The clinical response depends on the degree of elevation: mild increases may prompt dose reduction or frequency adjustment; significant elevations may require a therapeutic phlebotomy (blood donation) and protocol modification. This is why hematocrit monitoring is non-negotiable on TRT, not optional.

Do I need an aromatase inhibitor on TRT?

Not necessarily — and many patients don’t. Aromatase inhibitors (AIs) block the conversion of testosterone to estradiol, but their use is not appropriate as a routine addition to every TRT protocol. AIs are considered when estradiol rises to a level producing clear symptoms or clinically concerning values, and even then, the primary intervention is often dose or frequency adjustment. Reflexive AI prescribing is a pattern to avoid; estrogen plays important physiologic roles in men.

Is TRT safe for men with cardiovascular risk factors?

The cardiovascular profile of TRT has been extensively studied, most recently in the TRAVERSE trial, which found no significant increase in major cardiovascular events in men with pre-existing cardiovascular risk who received testosterone therapy. Men with cardiovascular risk factors are evaluated carefully at baseline, and lipid and blood pressure parameters are monitored over time. TRT is not a contraindication for men with managed cardiovascular risk; it requires thoughtful monitoring.

Can I stop TRT if I change my mind?

Yes. TRT can be discontinued. After stopping, endogenous testosterone production — which is suppressed during therapy — typically begins recovering, though the timeline varies based on duration of therapy, age, and individual factors. Some men experience a period of lower-than-baseline testosterone during the recovery phase. A structured discontinuation plan, rather than abrupt stopping, is generally preferred when patients decide to come off therapy.

What is the difference between total and free testosterone?

Total testosterone measures all testosterone in circulation — both bound to proteins (primarily SHBG and albumin) and unbound. Free testosterone represents the unbound fraction that is biologically active and available to tissues. Men with elevated SHBG may have adequate total testosterone but low free testosterone, producing genuine hypogonadal symptoms at total T values that appear normal on a standard report. Both values matter in a comprehensive evaluation.

How does TRT interact with sleep apnea?

Testosterone can worsen obstructive sleep apnea in some men. Pre-existing undiagnosed sleep apnea is a consideration during candidacy evaluation — not necessarily a contraindication, but a condition that warrants identification and treatment before or during TRT. Men who develop new or worsening snoring or daytime sleepiness on therapy should be screened.

What makes Lite Medical’s TRT program different?

Physician oversight at every step — not just at initiation. Many hormone clinics delegate monitoring visits to non-physician staff and only involve a doctor when something goes wrong. At Lite Medical, a physician reviews lab results, makes dose adjustment decisions, and remains the clinical point of contact throughout your therapy. Cash-pay pricing eliminates insurance restrictions on lab frequency and protocol design. We also don’t apply a one-size protocol to every patient; the evaluation and monitoring are individualized from the first visit.

Related Lite Medical Services

TRT in Edina: What Your First Appointment at Lite Medical Looks Like
Low Testosterone in Minneapolis: Signs, Labs, and When TRT Actually Helps
Free vs. Total Testosterone: What Minneapolis Patients Need to Know Before Starting TRT
TRT and Cardiovascular Health in Minneapolis: What the Latest Evidence Says
TRT Monitoring in Edina: Labs We Check and Why Timing Matters

References

U.S. Food and Drug Administration (FDA) — testosterone product labeling and prescribing information
National Institutes of Health (NIH) — MedlinePlus: Testosterone
Endocrine Society Clinical Practice Guidelines — Testosterone Therapy in Men with Hypogonadism
American Urological Association (AUA) — Evaluation and Management of Testosterone Deficiency

Medical Disclaimer

This article is intended for educational purposes only and should not be interpreted as personalized medical advice. Medical decisions should be made in consultation with a licensed healthcare professional who is familiar with your medical history. Treatment plans are individualized, and results vary. Lite Medical PLLC does not provide emergency medical care.

Medication & Regulatory Disclosure

Testosterone replacement therapy contains testosterone, which is classified as a Schedule III controlled substance under federal law. FDA-approved testosterone formulations are available in several delivery forms, including injectable, topical, and nasal preparations. Compounded testosterone preparations are not FDA-approved but may be prescribed by licensed physicians when clinically appropriate and in accordance with applicable state and federal regulations. All treatment decisions, including formulation selection and dosing, must be made by a licensed physician following a thorough clinical evaluation.